S
Spyre Therapeutics
In HouseSpyre Therapeutics is a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler treatment experience for patients. Spyre's pipeline includes investigational extended half-life antibodies targeting α4β7, TL1A, IL-23, and IL-17A/F, as well as rational combination programs.
Hiring by Category
In-House Legal1Legal Tech1
Promote your listings on LegalTech Roles
Get featured placement, priority search ranking, and newsletter distribution for your job listings.